About: Theravance Biopharma, Inc., a biopharmaceutical company, develops and commercializes medicines in the United States. It offers YUPELRI, an once-daily, nebulized long-acting muscarinic antagonist for the treatment of chronic obstructive pulmonary disease (COPD); and Ampreloxetine an investigational, once-daily norepinephrine reuptake inhibitor, Which is in Phase 3 clinical trials for symptomatic neurogenic orthostatic hypotension (nOH) in patients with Multiple System Atrophy (MSA). It has a strategic collaboration agreement with Viatris Inc. for the development and commercialization of revefenacin, including YUPELRI inhalation solution. Theravance Biopharma, Inc. was incorporated in 2013 and is based in South San Francisco, California.
Sector: Healthcare
Industry: Biotechnology
Latest price: $17.04 (+0.03%)
TBPH NASDAQ Theravance Biopharma Inc
Theravance Biopharma Inc share price
TBPH price activity
Last Price
$17.040
Change (24hr)
0.01 USD (0.03%)
Volume
1.37M
Volume (4w avg)
-
Open
$17.06
Day Range
$17.03 - $17.07
Previous Close
$17.03
Last Trade
23 Sep, 7:35 pm GMT+0
Delayed
23 Sep, 7:35 pm GMT+0
TBPH price performance
Delayed
23 Sep, 7:35 pm GMT+0
TBPH Market Signals